Moshe Olshansky

Dr. Moshe Olshansky

orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2004 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
ELErez Y Levanon
Erez Y Levanon
EEEli Eisenberg
Eli Eisenberg
RYRodrigo Yelin
Rodrigo Yelin
SNSergey Nemzer
Sergey Nemzer
MHMartina Hallegger
Martina Hallegger
MJMichael Jantsch
Michael Jantsch

1 September 2019 in Cell Reports
Verified
Journal Article
Open access
THTimothy S.C. Hinks
Timothy S.C. Hinks
EMEmanuele Marchi
Emanuele Marchi
MJMaisha Jabeen
Maisha Jabeen
MOMoshe Olshansky
Moshe Olshansky
AKAyako Kurioka
Ayako Kurioka
JMJames McCluskey
James McCluskey
Mucosal-associated invariant T (MAIT) cells are MR1-restricted innate-like T cells conserved across mammalian species, including mice and humans. By sequencing RNA from sorted MR1-5-OP-RU tetramer+ cells derived from either human blood or murine lungs, we define the basic transcriptome of an activated MAIT cell in both species and demonstrate how this profile changes during the resolution of infection and during reinfection. We observe strong similarities between MAIT cells in humans and mice. In both species, activation leads to strong expression of pro-inflammatory cytokines and chemokines as well as a strong tissue repair signature, recently described in murine commensal-specific H2-M3-restricted T cells. Transcriptomes of MAIT cells and H2-M3-specific CD8+ T cells displayed the most similarities to invariant natural killer T (iNKT) cells when activated, but to γδ T cells after the resolution of infection. These data define the requirements for and consequences of MAIT cell activation, revealing a tissue repair phenotype expressed upon MAIT cell activation in both species.

7 March 2016 in Nature Immunology
Verified
Journal Article
Open access
PDF file
AXAnnie Xin
Annie Xin
FMFrederick Masson
Frederick Masson
YLYang Liao
Yang Liao
SPSimon Preston
Simon Preston
TGTianxia Guan
Tianxia Guan
AKAxel Kallies
Axel Kallies
Using genetic approaches and transcriptional profiling, Kallies and colleagues reveal a common program of effector CD8+ T cell differentiation that is regulated by the cooperation of IL-2 and IL-12 signaling and the combined activities of the transcriptional regulators Blimp-1 and T-bet. T cell responses are guided by cytokines that induce transcriptional regulators, which ultimately control differentiation of effector and memory T cells. However, it is unknown how the activities of these molecular regulators are coordinated and integrated during the differentiation process. Using genetic approaches and transcriptional profiling of antigen-specific CD8+ T cells, we reveal a common program of effector differentiation that is regulated by IL-2 and IL-12 signaling and the combined activities of the transcriptional regulators Blimp-1 and T-bet. The loss of both T-bet and Blimp-1 leads to abrogated cytotoxic function and ectopic IL-17 production in CD8+ T cells. Overall, our data reveal two major overlapping pathways of effector differentiation governed by the availability of Blimp-1 and T-bet and suggest a model for cytokine-induced transcriptional changes that combine, quantitatively and qualitatively, to promote robust effector CD8+ T cell differentiation.

15 August 2016 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
Adrian A AchuthanAdrian A Achuthan
Adrian A Achuthan
ACAndrew D. Cook
Andrew D. Cook
MLMing-Chin Lee
Ming-Chin Lee
RSReem Saleh
Reem Saleh
HKHsu-Wei Khiew
Hsu-Wei Khiew
JHJohn A. Hamilton
John A. Hamilton
Data from preclinical and clinical studies have demonstrated that granulocyte macrophage colony-stimulating factor (GM-CSF) can function as a key proinflammatory cytokine. However, therapies that directly target GM-CSF function could lead to undesirable side effects, creating a need to delineate downstream pathways and mediators. In this work, we provide evidence that GM-CSF drives CCL17 production by acting through an IFN regulatory factor 4–dependent (IRF4-dependent) pathway in human monocytes, murine macrophages, and mice in vivo. In murine models of arthritis and pain, IRF4 regulated the formation of CCL17, which mediated the proinflammatory and algesic actions of GM-CSF. Mechanistically, GM-CSF upregulated IRF4 expression by enhancing JMJD3 demethylase activity. We also determined that CCL17 has chemokine-independent functions in inflammatory arthritis and pain. These findings indicate that GM-CSF can mediate inflammation and pain by regulating IRF4-induced CCL17 production, providing insights into a pathway with potential therapeutic avenues for the treatment of inflammatory diseases and their associated pain.

6 April 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
BHBenjamin C. Hitz
Benjamin C. Hitz
JLJin-Wook Lee
Jin-Wook Lee
OJOtto Jolanki
Otto Jolanki
MKMeenakshi S. Kagda
Meenakshi S. Kagda
KGKeenan Graham
Keenan Graham
JCJ. Michael Cherry
J. Michael Cherry
The Encyclopedia of DNA elements (ENCODE) project is a collaborative effort to create a comprehensive catalog of functional elements in the human genome. The current database comprises more than 19000 functional genomics experiments across more than 1000 cell lines and tissues using a wide array of experimental techniques to study the chromatin structure, regulatory and transcriptional landscape of the Homo sapiens and Mus musculus genomes. All experimental data, metadata, and associated computational analyses created by the ENCODE consortium are submitted to the Data Coordination Center (DCC) for validation, tracking, storage, and distribution to community resources and the scientific community. The ENCODE project has engineered and distributed uniform processing pipelines in order to promote data provenance and reproducibility as well as allow interoperability between genomic resources and other consortia. All data files, reference genome versions, software versions, and parameters used by the pipelines are captured and available via the ENCODE Portal. The pipeline code, developed using Docker and Workflow Description Language (WDL; https://openwdl.org/ ) is publicly available in GitHub, with images available on Dockerhub ( https://hub.docker.com ), enabling access to a diverse range of biomedical researchers. ENCODE pipelines maintained and used by the DCC can be installed to run on personal computers, local HPC clusters, or in cloud computing environments via Cromwell. Access to the pipelines and data via the cloud allows small labs the ability to use the data or software without access to institutional compute clusters. Standardization of the computational methodologies for analysis and quality control leads to comparable results from different ENCODE collections - a prerequisite for successful integrative analyses. Database URL: https://www.encodeproject.org/

1 May 2013 in The Journal of Immunology
Verified
Journal Article
Closed access
FMFrederick Masson
Frederick Masson
MMMartina Minnich
Martina Minnich
MOMoshe Olshansky
Moshe Olshansky
IBIvan Bilic
Ivan Bilic
AMAdele M Mount
Adele M Mount
GBGabrielle T. Belz
Gabrielle T. Belz
The transcription factor inhibitor of DNA binding (Id)2 modulates T cell fate decisions, but the molecular mechanism underpinning this regulation is unclear. In this study we show that loss of Id2 cripples effector differentiation and instead programs CD8+ T cells to adopt a memory fate with increased Eomesodermin and Tcf7 expression. We demonstrate that Id2 restrains CD8+ T cell memory differentiation by inhibiting E2A-mediated direct activation of Tcf7 and that Id2 expression level mirrors T cell memory recall capacity. As a result of the defective effector differentiation, Id2-deficient CD8+ T cells fail to induce sufficient Tbx21 expression to generate short-lived effector CD8+ T cells. Our findings reveal that the Id2/E2A axis orchestrates T cell differentiation through the induction or repression of downstream transcription factors essential for effector and memory T cell differentiation.